dexmedetomidine has been researched along with phenylephrine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barney, JA; Colinco, MD; Ebert, TJ; Hall, JE; Uhrich, TD | 1 |
| Lassila, R; Mustonen, P; Savola, J | 1 |
| Hopwood, SE; Stamford, JA | 1 |
| Bousquet, P; Feldman, J; Sy, GY | 1 |
| Dohi, S; Iida, H; Iida, M; Michino, T; Ohata, H | 1 |
| Eisenach, JH; Hesse, C; Joyner, MJ; Moyer, TP; Nicholson, WT; Sviggum, HP; Wilkins, BW | 1 |
| Dinenno, FA; Kirby, BS; Markwald, RR; Smith, EG; Voyles, WF | 1 |
| Donato, AJ | 1 |
| Charkoudian, N; Eisenach, JH; Hesse, C; Joyner, MJ; Moyer, TP; Nicholson, WT; Sviggum, HP; Wilkins, BW | 1 |
| Gul, H; Seyrek, M; Ulusoy, HB; Yildirim, V; Yildiz, O | 1 |
| Kohase, H; Makino, K; Sanada, T; Umino, M | 1 |
| Kurnik, D; Muszkat, M; Sofowora, GG; Stein, CM; Wood, AJ | 1 |
| Akkila, J; Posti, JP; Ruohonen, S; Scheinin, M; Snapir, A; Valve, L | 1 |
| Crecelius, AR; Dinenno, FA; Kirby, BS; Voyles, WF | 1 |
| Yamazaki, F; Yuge, N | 1 |
| Bennett-Guerrero, E; Habib, AS; Hale, B; Klinger, RY; White, WD | 1 |
| Fels, RJ; Kenney, MJ; Larsen, BT; Mason, D; McMurphy, RM | 1 |
| Andtbacka, RH; Gifford, JR; Hyngstrom, JR; Ives, SJ; Mueller, MT; Park, SY; Richardson, RS; Treiman, GS; Trinity, JD; Ward, C | 1 |
| Byon, HJ; Cho, Y; Han, JY; Kang, S; Lee, SH; Ok, SH; Sohn, JT | 1 |
| Ambrus, R; Eriksen, T; Mikkelsen, MLG; Miles, JE; Moltke, FB; Poulsen, HH; Rasmussen, R | 1 |
| Bock, JM; Casey, DP; Feider, AJ; Hanada, S; Hughes, WE; Iwamoto, E; Kruse, NT; Ueda, K | 1 |
| Kobayashi, K; Kohase, H; Nagasaka, H; Ohno, S; Sakagami, H; Uchida, S | 1 |
| Kobluk, K; Pypendop, BH | 1 |
| Honkavaara, J; Huuskonen, V; Pesonen, T; Raekallio, M; Restitutti, F; Vainio, O | 1 |
7 trial(s) available for dexmedetomidine and phenylephrine
| Article | Year |
|---|---|
The effects of increasing plasma concentrations of dexmedetomidine in humans.
Topics: Adrenergic alpha-Agonists; Adult; Conscious Sedation; Dexmedetomidine; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Gas Chromatography-Mass Spectrometry; Hemodynamics; Humans; Infusions, Intravenous; Male; Mental Recall; Norepinephrine; Phenylephrine; Pressoreceptors; Psychometrics; Regression Analysis | 2000 |
Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Blood Pressure; Cholinergic Antagonists; Dexmedetomidine; Drug Therapy, Combination; Female; Ganglion Cysts; Glycopyrrolate; Health; Humans; Male; Phenylephrine; Receptors, Adrenergic, alpha-2; Trimethaphan; Valsalva Maneuver | 2007 |
Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade.
Topics: Adrenergic alpha-Agonists; Adult; Autonomic Nerve Block; Baroreflex; Cardiac Output; Cardiovascular System; Catecholamines; Dexmedetomidine; Female; Ganglionic Blockers; Glycopyrrolate; Heart Rate; Humans; Male; Muscarinic Antagonists; Phenylephrine; Sympathetic Nervous System; Trimethaphan | 2008 |
Dorsal hand vein responses to the α₁-adrenoceptor agonist phenylephrine do not predict responses to the α₂-adrenoceptor agonist dexmedetomidine.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adult; Age Factors; Body Mass Index; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Humans; Male; Phenylephrine; Temperature; Vasoconstriction; Vasoconstrictor Agents; Veins; Young Adult | 2011 |
Impaired modulation of postjunctional α
Topics: Adenosine Triphosphate; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Case-Control Studies; Dexmedetomidine; Female; Forearm; Humans; Muscle Contraction; Muscle, Skeletal; Phenylephrine; Postmenopause; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vasoconstriction; Young Adult | 2018 |
Effects of dopamine, norepinephrine or phenylephrine on the prevention of hypotension in isoflurane-anesthetized cats administered vatinoxan or vatinoxan and dexmedetomidine.
Topics: Anesthetics, Inhalation; Animals; Blood Pressure; Dexmedetomidine; Dopamine; Heart Rate; Hypotension; Isoflurane; Male; Norepinephrine; Phenylephrine; Quinolizines | 2022 |
Cardiovascular effects of dobutamine, norepinephrine and phenylephrine in isoflurane-anaesthetized dogs administered dexmedetomidine-vatinoxan.
Topics: Anesthetics, Inhalation; Animals; Blood Pressure; Dexmedetomidine; Dobutamine; Dog Diseases; Dogs; Hypotension; Isoflurane; Norepinephrine; Phenylephrine; Saline Solution | 2022 |
17 other study(ies) available for dexmedetomidine and phenylephrine
| Article | Year |
|---|---|
Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Binding Sites; Binding, Competitive; Blood Platelets; Dexmedetomidine; Drug Evaluation, Preclinical; Epinephrine; Humans; Imidazoles; Phenylephrine; Platelet Aggregation Inhibitors; Prazosin; Receptors, Adrenergic, alpha-2; Yohimbine | 2000 |
Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Desipramine; Dexmedetomidine; Electric Stimulation; Electrophysiology; Imidazoles; In Vitro Techniques; Indoles; Isoindoles; Isoquinolines; Male; Norepinephrine; Phenylephrine; Piperazines; Prazosin; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Serotonin | 2001 |
Opposite to alpha2-adrenergic agonists, an imidazoline I1 selective compound does not influence reflex bradycardia in rabbits.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Autonomic Nervous System; Baroreflex; Blood Pressure; Bradycardia; Brain Stem; Cyclopropanes; Dexmedetomidine; Drug Interactions; Drug Synergism; Enzyme Inhibitors; Heart; Heart Rate; Imidazoline Receptors; Male; Nitric Oxide; Nitric Oxide Synthase; Oxazoles; Phenylephrine; Pyrroles; Rabbits; Receptors, Adrenergic, alpha-2; Receptors, Drug; Reticular Formation; Rilmenidine; Solitary Nucleus | 2006 |
Effects of dexmedetomidine on cerebral circulation and systemic hemodynamics after cardiopulmonary resuscitation in dogs.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Blood Pressure; Cardiopulmonary Resuscitation; Cardiotonic Agents; Cerebrovascular Circulation; Dexmedetomidine; Dogs; Electric Countershock; Heart Rate; Phenylephrine; Time Factors | 2006 |
Ageing and leg postjunctional alpha-adrenergic vasoconstrictor responsiveness in healthy men.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Aged; Aging; Blood Flow Velocity; Dexmedetomidine; Dose-Response Relationship, Drug; Femoral Artery; Humans; Laser-Doppler Flowmetry; Leg; Male; Middle Aged; Norepinephrine; Phenylephrine; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Reference Values; Research Design; Sympathetic Nervous System; Tyramine; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Ageing and vascular adrenoceptor desensitization: too little, too late?
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Aged; Aging; Blood Flow Velocity; Dexmedetomidine; Femoral Artery; Humans; Leg; Male; Middle Aged; Norepinephrine; Phenylephrine; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Reference Values; Sympathetic Nervous System; Tyramine; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Dexmedetomidine produces dual alpha2-adrenergic agonist and alpha1-adrenergic antagonist actions on human isolated internal mammary artery.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Coronary Artery Bypass; Dexmedetomidine; Female; Humans; Male; Mammary Arteries; Middle Aged; Phenylephrine; Potassium Chloride; Prazosin; Vasoconstriction; Yohimbine | 2007 |
Effects of alpha-adrenergic agonists on pain modulation in diffuse noxious inhibitory control.
Topics: Adrenergic alpha-Agonists; Adrenergic Antagonists; Animals; Dexmedetomidine; Electromyography; Injections, Spinal; Male; Nerve Fibers, Unmyelinated; Nerve Net; Neural Inhibition; Nociceptors; Pain; Phentolamine; Phenylephrine; Rats; Rats, Wistar | 2009 |
Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adult; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Hand; Humans; Male; Models, Cardiovascular; Phenylephrine; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Signal Transduction; Vasoconstriction; Young Adult | 2011 |
Modulation of postjunctional α-adrenergic vasoconstriction during exercise and exogenous ATP infusions in ageing humans.
Topics: Adenosine; Adenosine Triphosphate; Adrenergic alpha-Agonists; Aged; Aging; Dexmedetomidine; Exercise; Female; Forearm; Hand Strength; Humans; Hyperemia; Male; Middle Aged; Muscle Contraction; Muscle, Skeletal; Phenylephrine; Ultrasonography, Doppler; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2011 |
Limb-specific differences in the skin vascular responsiveness to adrenergic agonists.
Topics: Administration, Cutaneous; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Agonists; Analysis of Variance; Blood Pressure; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Humans; Isoproterenol; Laser-Doppler Flowmetry; Lower Extremity; Male; Microdialysis; Nonlinear Dynamics; Norepinephrine; Phenylephrine; Regional Blood Flow; Regression Analysis; Skin; Skin Temperature; Time Factors; Upper Extremity; Vascular Capacitance; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2011 |
Hemodynamic impact of dexmedetomidine administration in 15,656 noncardiac surgical cases.
Topics: Academic Medical Centers; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Atropine; Blood Pressure; Bradycardia; Databases, Factual; Dexmedetomidine; Epinephrine; Female; Heart Rate; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Phenylephrine; Retrospective Studies; Vasoconstrictor Agents | 2012 |
Dexmedetomidine and regulation of splenic sympathetic nerve discharge.
Topics: Animals; Blood Pressure; Dexmedetomidine; Dose-Response Relationship, Drug; Hypnotics and Sedatives; Male; Phenylephrine; Rats, Inbred F344; Spleen; Sympathetic Nervous System; Sympathomimetics | 2014 |
α1- and α2-adrenergic responsiveness in human skeletal muscle feed arteries: the role of TRPV ion channels in heat-induced sympatholysis.
Topics: Acetylcholine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Arteries; Dexmedetomidine; Female; Hot Temperature; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Skeletal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitroprusside; Phenylephrine; Potassium Chloride; Ruthenium Red; Sulfonamides; Sympatholytics; TRPV Cation Channels; Vasoconstriction | 2014 |
Dexmedetomidine Inhibits Phenylephrine-induced Contractions via Alpha-1 Adrenoceptor Blockade and Nitric Oxide Release in Isolated Rat Aortae.
Topics: Adrenergic Agonists; Animals; Aorta; Dexmedetomidine; In Vitro Techniques; Male; Muscle Contraction; Nitric Oxide; Phenoxybenzamine; Phenylephrine; Rats; Receptors, Adrenergic; Serotonin | 2017 |
The influence of norepinephrine and phenylephrine on cerebral perfusion and oxygenation during propofol-remifentanil and propofol-remifentanil-dexmedetomidine anaesthesia in piglets.
Topics: Anesthesia; Anesthetics, Intravenous; Animals; Blood Circulation; Cerebral Cortex; Dexmedetomidine; Hypnotics and Sedatives; Norepinephrine; Oxygen; Phenylephrine; Piperidines; Propofol; Remifentanil; Swine; Vasoconstrictor Agents | 2018 |
Induction of Non-Apoptotic Cell Death by Adrenergic Agonists in Human Oral Squamous Cell Carcinoma Cell Lines.
Topics: Adrenergic Agonists; Antineoplastic Agents; Carcinoma, Squamous Cell; Catalase; Cell Death; Cells, Cultured; Child; Clonidine; Dexmedetomidine; DNA Fragmentation; Epinephrine; Humans; Isoproterenol; Mouth Neoplasms; Phenylephrine; Superoxide Dismutase | 2019 |